Owens & Minor ( (OMI) ) has shared an announcement.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Owens & Minor reported a 5% rise in third-quarter revenue to $2.7 billion, driven by robust demand in Patient Direct and Medical Distribution. Despite a GAAP net loss of $13 million, adjusted earnings per share stood at $0.42. The company significantly reduced its debt by nearly $200 million, bolstering its financial position. Looking ahead, Owens & Minor anticipates sequential growth and improved cash flow, aiming for a revenue range of $10.6 to $10.8 billion for 2024.
Find detailed analytics on OMI stock on TipRanks’ Stock Analysis page.
